Increase in body weight after pramipexole treatment in Parkinson's disease

Movement Disorders

Volumn 21, Issue 11, 2006, Pages 1972-1974

  Kumru, Hatice ^a   Santamaria, Joan ^a   Valldeoriola, Francesc ^a   Marti, Maria J ^a   Tolosa, Eduardo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Parkinson's disease; Pramipexole; Weight gain

Indexed keywords

AMANTADINE; AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; CARBIDOPA PLUS LEVODOPA; CLOMIPRAMINE; DOPAMINE 3 RECEPTOR; ENTACAPONE; PRAMIPEXOLE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; DEPRESSION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; DYSPHAGIA; EATING DISORDER; FEEDING BEHAVIOR; FEMALE; HAMILTON SCALE; HUMAN; HUNGER; LIMBIC SYSTEM; MAINTENANCE DRUG DOSE; MALE; NAUSEA; OUTCOME ASSESSMENT; PARKINSON DISEASE; PERIPHERAL EDEMA; PRIORITY JOURNAL; RATING SCALE; SIDE EFFECT; VOMITING; WEIGHT GAIN;

AFFECT; AGED; ANTIPARKINSON AGENTS; BENZOTHIAZOLES; BODY MASS INDEX; BODY WEIGHT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOVEMENT; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 33845224571     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21086     Document Type: Article

References (15)

1. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
2. Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A. Weight loss in Parkinson's disease. Ann Neurol 2003;53:676-679.
3. Macia F, Perlemoine C, Coman I, et al. Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight. Mov Disord 2004;19:206-212.
4. Ondo WG, Ben-Aire L, Jankovic J, Lai E, Contant C, Grossman R. Weight gain following unilateral pallidotomy in Parkinson's disease. Acta Neurol Scand 2000;101:79-84.
5. Toth MJ, Fishman PS, Poehlinan ET. Free-living daily energy expenditure in patients with Parkinson's disease. Neurology 1997; 48:88-91.
6. Lang AE, Lozano A, Tasker R, Duff J, Saint-Cyr J, Trepanier L. Neuropsychological and behavioral changes and weight gain after medial pallidotomy. Ann Neurol 1997;41:834-835.
7. Palhagen S, Lorefalt B, Carlsson M, et al. Does L-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease? Acta Neurol Scand 2005; 111: 12-20.
8. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
9. Szczypka MS, Rainey MA, Palmiter RD. Dopamine is required for hyperphagia in Lep(ob/ob) mice. Nat Genet 2000;25:102-104.
10. Maldonado-Irizarry CS, Swanson CJ, Kelley AE. Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J Neurosci 1995;15:6779-6788.
11. Szczypka MS, Kwok K, Brot MD, et al. Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron 2001;30:819-828.
12. Schwartz JC, Levesque D, Martres MP, Sokoloff P. Dopamine D3 receptor: basic and clinical aspects. Clin Neuropharmacol 1993; 16:295-314.
13. Casper RC. Depression and eating disorders. Depress Anxiety 1998;8(Suppl. 1):96-104.
14. Fava M. Weight gain and antidepressants. J Clin Psychiatry 2000; 61(Suppl. 1):37-41.
15. Lieberman A, Ranhosky A, Korts D. Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study. Neurology 1997; 49:162-168.